Thank you very much, Deputy Presiding Officer, and I thank everyone for their contributions to the debate this afternoon. We heard at the outset from Laura Anne Jones. I thank her for her very kind words, and she emphasised once again the lack of staff and the long historic waiting lists, but that things have not necessarily improved with people going without diagnosis for long periods.

Rhun then talked about a very sad family history, and I extend my sympathies to Rhun and to everyone else who talked about their personal circumstances. But he talked about the need for a national cancer plan and emphasised that need for a clear strategy and focus, and then that we see the need for diagnostic hubs, early screening and a clear workforce plan and so forth—that need to have the strategy in place.

Janet Finch-Saunders mentioned the number of people getting treatment being lower than the target, as we heard, and emphasising the need for a strategy and also emphasising the need to have clear advice for patients in this case.

Russell George—thank you very much, Russ, for your very kind words, again emphasising the impact of the pandemic and calling for the need to reduce waiting times and emergency responses in order to have a quick diagnosis, and to ensure that people do survive because of a rapid diagnosis. Thank you very much to Russell George. 

Jenny Rathbone made some very important points, particularly at the end, talking about the pancreatic cancer situation and the important role played by nutritionists and nutrition for patients, and multidisciplinary teams when it comes to detecting cancer.

And then, finally, I thank the Minister for her response. You mentioned the investment that is being made. Of course, we do recognise the impact of the pandemic and we offer great thanks, evidently, for any additional investment. You’re talking about figures that are beyond my understanding—£0.25 billion; very great figures—and you talked about a clinical framework, but, again, what we didn’t hear was the word ‘strategy’. We heard ‘framework’ and the different ‘frameworks’, but you didn’t talk about a national strategy, which does mean that Wales will be without a clear cancer strategy. Are these frameworks together going to constitute some kind of strategy? That’s not clear, so I’m looking forward to seeing what the cancer strategy of the Government will be in its entirety.

And despite this investment of millions of pounds in capital funding mainly—that’s what I think that is—there’s been no mention made of funding to fill this gap in the staffing, which continues. As we mentioned, the number of radiologists is far lower in Wales than in other countries on the continent, and we need to fill that gap and ensure that we have those staff. So, I’m looking forward to seeing what investment you will be putting in to this in order to fill that gap. Because if we are going to tackle this issue and ensure that people do have an early diagnosis and then can survive this illness, then we have to have the staff in place in order to recognise the illness in the first place.  

There was no mention made of the Richards review and the lessons that you’ve learned from that review in England. There are important lessons there, I think, that the Welsh Government should pick up on. So, could you give some consideration to those lessons? If you make another statement in the Senedd, maybe you can talk about the lessons that you’re learning from that review. Thank you very much, Deputy Presiding Officer.